[Antagonism between anti-Parkinson drugs and neuroleptics. Apropos of various withdrawal experiences, a personal one among them (2nd part)].
D000328:Adult; D000978:Antiparkinson Agents / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000139:chemically induced*; D003863:Depression / Q000188:drug therapy; D004336:Drug Antagonism; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use
D000978:Antiparkinson Agents; D014149:Tranquilizing Agents
L'antagonisme entre correcteurs anti-parkinsoniens et neuroleptiques. A propos de diverses expériences de sevrage dont une personnelle (2e partie)